BETH IRWIN: Open Payments
NPI 1174976989 · BRANDON, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,991 in 99 payments from 16 companies in 2025. Trend: 2023 $2,326 · 2024 $2,229 · 2025 $1,991
Food & beverage: $1,991
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 30 | $660 |
| ABBVIE INC. | 13 | $233 |
| UCB, Inc. | 9 | $210 |
| Novartis Pharmaceuticals Corporation | 11 | $168 |
| AstraZeneca Pharmaceuticals LP | 7 | $136 |
| GlaxoSmithKline, LLC. | 6 | $106 |
| Lilly USA, LLC | 5 | $98 |
| ANI Pharmaceuticals, Inc. | 4 | $97 |
| Janssen Biotech, Inc. | 4 | $83 |
| Radius Health, Inc. | 3 | $55 |
Products named: KRYSTEXXA, RINVOQ, Bimzelx, EVENITY, COSENTYX, SAPHNELO, TAVNEOS, BENLYSTA.
Industry payments across FL — which companies pay providers there.
